⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RZLT News
Rezolute, Inc. Common Stock (NV)
Rezolute Announces Four Presentations at the Upcoming Annual Meeting of the Endocrine Society
globenewswire.com
RZLT
Form 8-K
sec.gov
RZLT
Rezolute Announces Positive Interim Data for its Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism
globenewswire.com
RZLT
Form 8-K
sec.gov
RZLT
Rezolute Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update
globenewswire.com
RZLT
Rezolute to Participate in Upcoming Investor Conferences
globenewswire.com
RZLT
Form 8-K
sec.gov
RZLT
Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting
globenewswire.com
RZLT
Rezolute, Inc. Investigated by the Portnoy Law Firm
globenewswire.com
RZLT
Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting
globenewswire.com
RZLT